LEGEND BIOTECH IRELAND LTD has a total of 27 patent applications. It decreased the IP activity by 37.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are WUHAN HEALTHGEN BIOTECHNOLOGY CORP, TIMMUNE BIOTECH INC and IG THERAPY.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | Chile | 2 | |
#5 | Colombia | 2 | |
#6 | Costa Rica | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Israel | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Mexico | 2 | |
#11 | Singapore | 2 | |
#12 | South Africa | 2 | |
#13 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Wang Lin | 22 |
#2 | Yang Lei | 21 |
#3 | Wang Pingyan | 21 |
#4 | Zhuang Qiuchuan | 20 |
#5 | Fan Xiaohu | 20 |
#6 | Hao Jiaying | 20 |
#7 | He Xian | 11 |
#8 | Zhao Dan | 10 |
#9 | Chou Chuan-Chu | 8 |
#10 | Xiaohu Fan | 3 |
Publication | Filing date | Title |
---|---|---|
CA2994579A1 | Chimeric antigen receptors based on single-domain antibodies and methods of use thereof |